The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels

P. Lissoni, A. Bastone, R. Sala, R. Mauri, F. Rovelli, S. Viviani, E. Bajetta, D. Esposti, G. Esposti, L. Di Bella, F. Fraschini

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

In order to investigate the pineal function and its relation with the hypophysis in human neoplasms, melatonin and GH serum levels were determined in 63 patients, 42 affected by solid tumours and 21 by lymphoma or leukaemia. In women with breast cancer PRL was also measured. Melatonin, GH and PRL were evaluated in 52 healthy subjects acting as controls. The oncological patients showed significantly higher mean melatonin serum levels than the control subjects. Mean melatonin values were lower in patients with solid tumours who had metastases, than in cases without metastases. Chemotherapy caused an evident decrease in melatonin levels. Surgery was followed by a fall in melatonin in patients without metastases. Mean GH serum levels observed in oncological patients were similar to those in control subjects and were not influenced by therapy. PRL levels were within the normal range in women suffering from breast cancer.

Original languageEnglish
Pages (from-to)949-957
Number of pages9
JournalEuropean Journal of Cancer and Clinical Oncology
Volume23
Issue number7
DOIs
Publication statusPublished - 1987

Fingerprint

Melatonin
Serum
Neoplasm Metastasis
Breast Neoplasms
Neoplasms
Pituitary Gland
Lymphoma
Healthy Volunteers
Leukemia
Reference Values
Drug Therapy

ASJC Scopus subject areas

  • Oncology

Cite this

The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels. / Lissoni, P.; Bastone, A.; Sala, R.; Mauri, R.; Rovelli, F.; Viviani, S.; Bajetta, E.; Esposti, D.; Esposti, G.; Di Bella, L.; Fraschini, F.

In: European Journal of Cancer and Clinical Oncology, Vol. 23, No. 7, 1987, p. 949-957.

Research output: Contribution to journalArticle

Lissoni, P, Bastone, A, Sala, R, Mauri, R, Rovelli, F, Viviani, S, Bajetta, E, Esposti, D, Esposti, G, Di Bella, L & Fraschini, F 1987, 'The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels', European Journal of Cancer and Clinical Oncology, vol. 23, no. 7, pp. 949-957. https://doi.org/10.1016/0277-5379(87)90340-3
Lissoni, P. ; Bastone, A. ; Sala, R. ; Mauri, R. ; Rovelli, F. ; Viviani, S. ; Bajetta, E. ; Esposti, D. ; Esposti, G. ; Di Bella, L. ; Fraschini, F. / The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels. In: European Journal of Cancer and Clinical Oncology. 1987 ; Vol. 23, No. 7. pp. 949-957.
@article{e9eab1dc1bcb47aa9314a8606c960986,
title = "The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels",
abstract = "In order to investigate the pineal function and its relation with the hypophysis in human neoplasms, melatonin and GH serum levels were determined in 63 patients, 42 affected by solid tumours and 21 by lymphoma or leukaemia. In women with breast cancer PRL was also measured. Melatonin, GH and PRL were evaluated in 52 healthy subjects acting as controls. The oncological patients showed significantly higher mean melatonin serum levels than the control subjects. Mean melatonin values were lower in patients with solid tumours who had metastases, than in cases without metastases. Chemotherapy caused an evident decrease in melatonin levels. Surgery was followed by a fall in melatonin in patients without metastases. Mean GH serum levels observed in oncological patients were similar to those in control subjects and were not influenced by therapy. PRL levels were within the normal range in women suffering from breast cancer.",
author = "P. Lissoni and A. Bastone and R. Sala and R. Mauri and F. Rovelli and S. Viviani and E. Bajetta and D. Esposti and G. Esposti and {Di Bella}, L. and F. Fraschini",
year = "1987",
doi = "10.1016/0277-5379(87)90340-3",
language = "English",
volume = "23",
pages = "949--957",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "7",

}

TY - JOUR

T1 - The clinical significance of melatonin serum determination in oncological patients and its correlations with GH and PRL blood levels

AU - Lissoni, P.

AU - Bastone, A.

AU - Sala, R.

AU - Mauri, R.

AU - Rovelli, F.

AU - Viviani, S.

AU - Bajetta, E.

AU - Esposti, D.

AU - Esposti, G.

AU - Di Bella, L.

AU - Fraschini, F.

PY - 1987

Y1 - 1987

N2 - In order to investigate the pineal function and its relation with the hypophysis in human neoplasms, melatonin and GH serum levels were determined in 63 patients, 42 affected by solid tumours and 21 by lymphoma or leukaemia. In women with breast cancer PRL was also measured. Melatonin, GH and PRL were evaluated in 52 healthy subjects acting as controls. The oncological patients showed significantly higher mean melatonin serum levels than the control subjects. Mean melatonin values were lower in patients with solid tumours who had metastases, than in cases without metastases. Chemotherapy caused an evident decrease in melatonin levels. Surgery was followed by a fall in melatonin in patients without metastases. Mean GH serum levels observed in oncological patients were similar to those in control subjects and were not influenced by therapy. PRL levels were within the normal range in women suffering from breast cancer.

AB - In order to investigate the pineal function and its relation with the hypophysis in human neoplasms, melatonin and GH serum levels were determined in 63 patients, 42 affected by solid tumours and 21 by lymphoma or leukaemia. In women with breast cancer PRL was also measured. Melatonin, GH and PRL were evaluated in 52 healthy subjects acting as controls. The oncological patients showed significantly higher mean melatonin serum levels than the control subjects. Mean melatonin values were lower in patients with solid tumours who had metastases, than in cases without metastases. Chemotherapy caused an evident decrease in melatonin levels. Surgery was followed by a fall in melatonin in patients without metastases. Mean GH serum levels observed in oncological patients were similar to those in control subjects and were not influenced by therapy. PRL levels were within the normal range in women suffering from breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=0023212048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023212048&partnerID=8YFLogxK

U2 - 10.1016/0277-5379(87)90340-3

DO - 10.1016/0277-5379(87)90340-3

M3 - Article

VL - 23

SP - 949

EP - 957

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 7

ER -